Re-exposure to heparin in uremic patients requiring hemodialysis with heparin-induced thrombocytopenia

J Thromb Haemost. 2010 Mar;8(3):616-8. doi: 10.1111/j.1538-7836.2009.03734.x. Epub 2009 Dec 24.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antibodies / blood
  • Anticoagulants / administration & dosage
  • Anticoagulants / adverse effects*
  • Anticoagulants / immunology
  • Drug Administration Schedule
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Heparin / administration & dosage
  • Heparin / adverse effects*
  • Heparin / immunology
  • Humans
  • Kidney Failure, Chronic / blood
  • Kidney Failure, Chronic / therapy*
  • Male
  • Platelet Aggregation / drug effects
  • Platelet Factor 4 / immunology
  • Predictive Value of Tests
  • Renal Dialysis / adverse effects*
  • Thrombocytopenia / chemically induced*
  • Thrombocytopenia / immunology
  • Thrombocytopenia / therapy
  • Thrombosis / blood
  • Thrombosis / etiology
  • Thrombosis / prevention & control*
  • Time Factors
  • Uremia / blood
  • Uremia / drug therapy*

Substances

  • Antibodies
  • Anticoagulants
  • Platelet Factor 4
  • Heparin